Revottack

AXP000134.1 · Oncolytic virus

Platform
vesicular stomatitis virus (recombinant)

Names

NameTypeSource
Revottackpreferred name, brandcurator, ctgov

Virus

Role
Oncolytic
Family
Rhabdoviridae
Virus
vesicular stomatitis Indiana virus (NCBI Taxonomy 11277)
Replication
replicating
Modifications
not described in the registration
Route
intravenous
Source
evidence

Approvals

No regulatory approval recorded.

Clinical trials (1)

TrialTitleStatusPhaseStartPrimary completionEnrolmentConditions
NCT05644509Study on the Treatment of Advanced Malignant Solid Tumor With Revottack and PD-1 InhibitorUnknownPhase 12022-122023-1210Advanced Solid Tumor

Recent changes

No changes recorded in its trials yet.

Notes

Named in NCT05644509 as 'vesicular stomatitis oncolytic virus injection (Revottack)', given intravenously with toripalimab at the Affiliated Hospital of Xuzhou Medical University. Construct, transgenes and developer are not stated anywhere found; NCIt holds only a generic concept C199297 (Oncolytic Vesicular Stomatitis Virus) that also carries an unrelated YSCH-01 synonym, so no ncit code is recorded. Possibly the same product as another Chinese oncolytic VSV (RT-01, VSV-02, OVV-01): unresolved.

How to cite

Revottack (AXP000134.1). The Abstractinator program registry, release 2026-11-17+2c46e992acfc. https://abstractinator.me/registry/AXP000134.html

Something wrong or missing? Suggest a correction (a GitHub issue; please link your evidence). Entry created 2026-11-11, updated 2026-11-11.